PALVELLA THERAPEUTICS INC (PVLA) Stock Income Statement
NASDAQ:PVLA - US6979471090 - Common Stock
59.77 USD
+3.06 (+5.4%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 42.81M | 25.90M | 31.42M | |||
| Operating Expenses | 15.39M | 14.00M | 58.65M | 69.38M | 83.25M | |||
| Research and Development | N/A | N/A | 41.80M | 52.98M | 66.66M | |||
| Selling, General, and Administrative Expenses | 3.65M | 5.94M | 16.85M | 16.39M | 16.59M | |||
| Operating Income | -15.39M | -14.00M | -15.84M | -43.47M | -51.83M | |||
| Interest Income/Expense | N/A | N/A | 1.85M | 721.00K | 4.00K | |||
| Other Income/Expense | 2.71M | -3.00M | 3.36M | 1.30M | 2.40M | |||
| Non Recurring Items | N/A | 0.00 | -13.91M | 8.17M | 3.69M | |||
| Income Before Taxes | -21.31M | -17.00M | -24.54M | -33.28M | -45.74M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | 0.00 | |||
| Net Income | -21.51M | -17.00M | -24.54M | -33.28M | -45.74M | |||
| EBITDA | N/A | N/A | -13.94M | -40.70M | -49.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -6.59 | -7.62 | -21.80 | -35.89 | -56.69 | |||
| Non GAAP EPS | N/A | N/A | N/A | -36.00 | -55.37 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | -57.33% | -128.47% | -145.58% | |||
| Operating Profit Margin | N/A | N/A | -37.01% | -167.84% | -164.97% | |||
All data in USD